HPIV3-vectored Ebola vaccine (EBOV GP)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPIV3-vectored Ebola vaccine (EBOV GP), covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein [Phase 1]